Why Cost Conversations Matter — Even for Surgical Irrigation

Mannitol/Sorbitol irrigation solution sits in an unusual cost category. At roughly $61 for 12,000 mL (four 3,000 mL bags), the product itself is inexpensive. Patients don't purchase it at a pharmacy or receive a separate line item for it. But the procedures that require Mannitol/Sorbitol — transurethral resection of the prostate (TURP), hysteroscopic surgery, and other transurethral procedures — can carry substantial out-of-pocket costs for patients, particularly those who are underinsured or on high-deductible health plans.

As a provider, you're in a unique position to help patients navigate the financial landscape surrounding these procedures. This guide covers what patients are actually paying, strategies for reducing costs, and how to build cost-awareness into your surgical workflow.

What Patients Are Actually Paying

Let's be clear about where the money goes. Patients are rarely, if ever, billed separately for Mannitol/Sorbitol irrigation. The cost burden comes from:

• Facility fees — Hospital and ambulatory surgery center charges for the procedure room, nursing staff, and equipment. These can range from $5,000 to $25,000+ depending on the facility and complexity.
• Surgeon fees — Professional fees for the operating surgeon, typically $1,500-$4,000 for a TURP.
• Anesthesia fees — Anesthesiologist charges, often $1,000-$3,000.
• Pre-op and post-op care — Labs, imaging, follow-up visits, and any required medications after the procedure.

For a patient with a $5,000 deductible who hasn't met it, a TURP could mean significant out-of-pocket exposure. And when the Mannitol/Sorbitol shortage delays procedures, patients may face multiple pre-op visits, repeated labs, and the stress of rescheduling — all adding indirect costs.

Manufacturer Savings Programs

Unlike branded retail medications, Mannitol/Sorbitol irrigation has no manufacturer savings programs, copay cards, or patient assistance programs. This is because:

• It's a hospital-use product, not a retail prescription
• Patients don't purchase it directly
• ICU Medical (the manufacturer) sells to hospitals and surgical centers, not consumers

The savings opportunity for Mannitol/Sorbitol lies not in the product's cost but in optimizing the overall procedural cost for the patient.

Strategies for Reducing Patient Costs

1. Choose the Right Facility

Facility fees vary dramatically between settings:

• Hospital outpatient departments (HOPDs) — Typically the most expensive option due to hospital overhead charges.
• Ambulatory surgery centers (ASCs) — Often 40-60% less expensive than hospital settings for the same procedure.
• Office-based procedures — When clinically appropriate, some procedures can be performed in an office setting at even lower cost.

If your patient's procedure can safely be performed at an ASC rather than a hospital, the savings can be thousands of dollars. This is especially relevant for straightforward TURP cases and diagnostic hysteroscopies.

2. Verify Insurance Coverage and Pre-Authorization

Help your scheduling team ensure that:

• The procedure is pre-authorized if required by the patient's plan
• The facility is in-network for the patient's insurance
• The anesthesiologist and any assisting providers are also in-network (surprise billing from out-of-network anesthesiologists remains a common pain point)
• The patient understands their estimated out-of-pocket responsibility before the surgery date

Many denials and unexpected bills come from administrative oversights that could have been caught pre-operatively.

3. Consider Alternative Irrigation Solutions When Appropriate

When Mannitol/Sorbitol is unavailable due to the current shortage, the choice of alternative irrigation may also affect cost:

• Glycine 1.5% — Generally comparable in cost; widely available
• Normal saline — Less expensive and eliminates hyponatremia risk, but requires bipolar electrosurgical equipment. If your facility has bipolar capability, this may be the most cost-effective and clinically safe option.
• Sterile water — The cheapest option but carries hemolysis risk; generally not recommended unless circumstances require it

Transitioning to bipolar TURP with saline irrigation can offer both clinical and financial advantages for the right patients. For a full comparison of alternatives to Mannitol/Sorbitol, see our patient-facing guide.

4. Timing the Procedure Strategically

For non-emergent procedures, timing can affect cost:

• Deductible status — If a patient has already met their annual deductible, scheduling the procedure in the same calendar year minimizes out-of-pocket costs.
• End-of-year scheduling — Patients who are close to meeting their deductible may benefit from scheduling other needed care first.
• Shortage timing — When irrigation solutions are on allocation, delays can push procedures into a new benefit year, potentially resetting deductibles. Proactive scheduling when supply is available can prevent this.

5. Connect Patients With Financial Assistance Resources

While there are no Mannitol/Sorbitol-specific assistance programs, several resources can help patients with overall surgical costs:

• Hospital financial assistance programs — Most hospitals are required to offer charity care or payment plans for patients who qualify. Encourage patients to ask about these programs before their procedure.
• State Medicaid programs — Patients who lose insurance or have very low income may qualify for Medicaid, which typically covers TURP and hysteroscopic procedures.
• Medicare coverage — For patients 65+, Medicare Part A covers inpatient surgery and Part B covers outpatient procedures. Ensure patients understand their Medicare supplement or Advantage plan coverage.
• Nonprofit assistance — Organizations like the Patient Advocate Foundation and HealthWell Foundation may help with procedure-related costs for qualifying patients.

Generic Alternatives and Therapeutic Substitution

Mannitol/Sorbitol irrigation is already a generic product — there is no branded equivalent that costs more. The real "substitution" conversation for providers centers on:

• Switching irrigation modality — Moving from monopolar electrosurgery (which requires nonelectrolytic irrigants like Mannitol/Sorbitol) to bipolar electrosurgery (which uses normal saline) eliminates the need for specialty irrigation solutions entirely.
• Adopting laser-based techniques — Holmium laser enucleation of the prostate (HoLEP) and other laser techniques use normal saline for irrigation, sidestepping the nonelectrolytic irrigant supply chain.
• Evaluating medical management first — For BPH patients, ensuring that medical therapy (Alpha-blockers like Tamsulosin, 5-alpha reductase inhibitors like Finasteride) has been adequately trialed before proceeding to surgery can avoid procedural costs altogether for appropriate patients.

Building Cost Conversations Into Your Workflow

Cost discussions shouldn't be an afterthought. Here's how to integrate them into your practice:

At the Initial Consultation

• Discuss the procedure, expected outcomes, and estimated costs up front
• Ask about insurance status and deductible progress
• Mention that facility choice can significantly impact cost
• Offer a written cost estimate when possible

At Pre-Op

• Confirm insurance pre-authorization is complete
• Verify all providers are in-network
• Provide the patient with a clear breakdown of expected charges
• Connect uninsured or underinsured patients with the hospital's financial counselor

At Discharge

• Ensure the patient knows what follow-up care is included vs. separate
• Provide billing contact information for questions
• Remind patients to review their Explanation of Benefits (EOB) when it arrives

Ongoing

• Track your facility's irrigation solution costs and usage patterns
• Evaluate whether transitioning to bipolar equipment could reduce costs and improve supply resilience
• Stay informed about the current supply situation so you can plan proactively

Final Thoughts

The cost of Mannitol/Sorbitol itself is negligible. But the procedures that use it — and the shortage that disrupts them — create real financial impact for patients. As a provider, you can make a meaningful difference by choosing cost-effective settings, ensuring insurance processes run smoothly, considering alternative surgical approaches, and having honest cost conversations early in the care journey.

For more provider resources, visit Medfinder for Providers. For clinical details, see our guides on how Mannitol/Sorbitol works, drug interactions, and side effect management.